Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:ergotamine
caffeine |
| gptkbp:ATCCode |
N02CA52
|
| gptkbp:contraindication |
pregnancy
coronary artery disease peripheral vascular disease |
| gptkbp:discontinued |
gptkb:United_States
|
| gptkbp:form |
gptkb:tablet
suppository |
| https://www.w3.org/2000/01/rdf-schema#label |
Cafergot
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
vasoconstriction
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting hypertension ischemia |
| gptkbp:usedFor |
migraine treatment
|
| gptkbp:bfsParent |
gptkb:Ergotamine
|
| gptkbp:bfsLayer |
7
|